Expression validation using extended NSCLC TCGA cohorts showed that CDH1, CDH2, and CDH3 genes were significantly upregulated in both LUAD and LUSC tumors compared to normal tissues (Figs. 2A, 2B). The gene discussed is CDH3; the disease is non-small cell lung carcinoma.